News & Industry Insights
Stay informed about Migibio announcements and developments in veterinary point-of-care diagnostics.
The Shift to Quantitative Point-of-Care Testing
Veterinary diagnostics is undergoing a decisive shift. Traditional qualitative rapid tests — which show a simple line or no line — are being replaced by quantitative fluorescence immunoassays that deliver an objective numerical concentration in minutes. This transition is driven by clinical demand for:
- Earlier diagnosis — quantitative biomarkers such as SDMA detect kidney disease before clinical signs appear.
- Objective results — instrument-read values eliminate subjective line interpretation.
- Serial monitoring — numerical trends reveal whether treatment is working, not just whether a pathogen is present.
Fluorescence immunochromatography (FICT) sits at the centre of this transformation. Learn more on our Core Technology page.
Why Point-of-Care Testing Matters
Point-of-care testing (POCT) moves diagnostics from the laboratory to the cage-side, enabling same-visit clinical decisions. For a complete overview of the technology, workflow design, and benefits, read our guide:
Company Updates
Migibio continues to expand its fluorescence immunochromatographic test portfolio and global distribution network across 30+ countries. Our ISO9001-certified manufacturing and GMP-quality systems underpin every product release.
For company background, certifications, and manufacturing capabilities, visit About Migibio. For technical documentation and support resources, see Support & Downloads.
Explore Our Knowledge Base
Our blog covers the science and practice of veterinary diagnostics:
- Canine Infectious Disease Testing: The Complete Guide
- Feline Infectious Disease Testing: The Complete Guide
- Veterinary Biomarker Monitoring: Kidney, Cardiac, and More
- Veterinary Laboratory Quality Control: A Complete Guide
For the latest articles, visit our Blog.